Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 2, 2009, Pages 233-235

  Weisenberg, Scott A ^a   Morgan, Daniel J ^b   Espinal Witter, Rosanny ^a   Larone, Davise H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Klebsiella pneumoniae; KPC

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CARBAPENEMASE; ERTAPENEM; IMIPENEM; MEROPENEM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENZYME SYNTHESIS; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; TRACHEOBRONCHITIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; UROSEPSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; FEMALE; GENES, BACTERIAL; HUMANS; IMIPENEM; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; THIENAMYCINS; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349254120     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.02.004     Document Type: Article

References (12)

1. Anderson K.F., Lonsway D.R., Rasheed J.K., Biddle J., Jenson B., McDougal L.K., Carey R.B., Thompson A., Stocker S., Limbago B., and Patel J.B. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45 (2007) 2723-2725
2. Bradford P.A., Bratu S., Urban C., Visalli M., Mariano N., Landman D., Rahal J.J., Brooks S., Cebular S., and Quale J. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin. Infect. Dis. 39 (2004) 55-60
3. Bratu S., Landman D., Haag R., Recco R., Eramo A., Alam M., and Quale J. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch. Intern. Med. 165 (2005) 1430
4. Deshpande L.M., Rhomberg P.R., Sader H.S., and Jones R.N. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States medical centers: report from the MYSTIC program (1999-2005). Diagn. Microb. Infect. Dis. 56 (2006) 367-372
5. Espinal-Witter R., Casal C.E., Fauntleroy K.A., and Larone D.H. Detection of Klebsiella pneumoniae carbapenemase (KPC) by Vitek 2 AST GN Card using ertapenem as the indicator. Abstracts of the American Society of Microbiology Annual Meeting; Toronto, Canada; May 21-25, 2007 (2007) Abstract C-044
6. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 13 (1985) 818-829
7. Landman D., Bratu S., Kochar S., Panwar M., Trehan M., Doymaz M., and Quale J. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J. Antimicrob. Chemother. 60 (2007) 78-82
8. Lomaestro B.M., Tobin E.H., Shang W., and Gootz T. The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin. Infect. Dis. 43 (2006) e26-e28
9. Sakka S.G., Glauner A.K., Bulitta J.B., Kinzig-Schippers M., Pfister W., Drusano G.L., and Sorgel F. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastin in critically ill patients in a randomized, controlled trial. Antimicrob. Agents Chemother. 51 (2007) 3304-3310
10. Wolter D.J., Kurpiel P.M., Woodford N., Palepou M.F., Goering R.V., and Hanson N.D. Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob. Agents Chemother. 53 (2008) 557-562
11. Woodford N., Tierno Jr. P.M., Young K., Tysall L., Palepou M.F., Ward E., Painter R.E., Suber D.F., Shanqu D., Silver L.L., Inglima K., Kornblum J., and Livermore D.M. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob. Agents Chemother. 48 (2004) 4793-4799
12. Yigit H., Queenan A.M., Anderson G.J., Domenech-Sanchez A., Biddle J.W., Steward C.D., Alberti S., Bush K., and Tenover F.C. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45 (2001) 1151-1161